Discover comprehensive details about Tolterodine, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

A total of 1022 patients (818 females, 204 males) aged 21 to 93 years were randomised into the study. Patients were enrolled in North America (53%), Europe (42%) and Australia (5%). These represented ...

The International Continence Society(ICS) has defined overactive bladder(OAB) as urinary urgency with orwithout urge incontinence, usually with frequencyand nocturia, in the absence ofproven infection ...

Review the side-effects of Tolterodine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

As Table II indicates, oxybutynin XL is the dominant therapeutic option. Not only does it provide superior effectiveness results compared with tolterodine IR, it also leads to lower overall costs.

Although anticholinergic medications are widely used to treat urinary incontinence in the elderly, the fact that their use may be associated with memory loss and visual hallucinations has not been ...

To assess the safety and efficacy of a combination of doxazosin and tolterodine in men with BOO, and BOO plus OABS. On the basis of URODYNAMIC ASSESSMENT, men with lower urinary tract symptoms were ...

Objective: To examine levels of persistence andcompliance as well as the economic impact ofextended-release tolterodine (tolterodine ER) versusimmediate-and extended-release oxybutynin (oxybutyninIR ...

Serlopitant, a neurokinin-1 receptor antagonist, offers no advantage over tolterodine for the treatment of adult overactive bladder (OAB), according to the results of a multicenter randomized ...

The Appraisal Committee reviewed the data available on the clinical and cost effectiveness of mirabegron, having considered evidence on the nature of overactive bladder (OAB) and the value placed on ...